Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 14;30(22):2852-2865.
doi: 10.3748/wjg.v30.i22.2852.

Enteric neuropathy in diabetes: Implications for gastrointestinal function

Affiliations
Review

Enteric neuropathy in diabetes: Implications for gastrointestinal function

Mona Mohamed Ibrahim Abdalla. World J Gastroenterol. .

Abstract

Diabetes, commonly known for its metabolic effects, also critically affects the enteric nervous system (ENS), which is essential in regulating gastrointestinal (GI) motility, secretion, and absorption. The development of diabetes-induced enteric neuropathy can lead to various GI dysfunctions, such as gastroparesis and irregular bowel habits, primarily due to disruptions in the function of neuronal and glial cells within the ENS, as well as oxidative stress and inflammation. This editorial explores the pathophysiological mechanisms underlying the development of enteric neuropathy in diabetic patients. Additionally, it discusses the latest advances in diagnostic approaches, emphasizing the need for early detection and intervention to mitigate GI complications in diabetic individuals. The editorial also reviews current and emerging therapeutic strategies, focusing on pharmacological treatments, dietary management, and potential neuromodulatory interventions. Ultimately, this editorial highlights the necessity of a multidisciplinary approach in managing enteric neuropathy in diabetes, aiming to enhance patient quality of life and address a frequently overlooked complication of this widespread disease.

Keywords: Diabetes; Diabetic neuropathy; Enteric nervous system; Enteric neuropathy; Gastrointestinal; Insulin resistance.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The author declares no conflict of interest for this article.

Figures

Figure 1
Figure 1
Mechanisms of diabetic enteric neuropathy. AGEs: Advanced glycation end-products.
Figure 2
Figure 2
Impact of diabetic enteric neuropathy on gastrointestinal tract. GERD: Gastroesophageal reflux disease.

References

    1. Hansen CS, Määttä LL, Andersen ST, Charles MH. The Epidemiology of Diabetic Neuropathy. In: Tesfaye S, Gibbons CH, Malik RA, Veves A, editors. Diabetic Neuropathy. Contemporary Diabetes. Humana, Cham, 2023: 5-36.
    1. Jones KL, Marathe CS, Wu T, Rayner CK, Horowitz M. Gastrointestinal Neuropathy. In: Tesfaye S, Gibbons CH, Malik RA, Veves A, editors. Diabetic Neuropathy. Contemporary Diabetes. Humana, Cham, 2023: 471-490.
    1. Bassi A, Bossa M, d’Alba L, Greco C, Casini A, Pellicano C, Simonelli M, Zampatti S. Gastrointestinal Autonomic Disorders. In: Micieli G, Hilz M, Cortelli P, editors. Autonomic Disorders in Clinical Practice. Springer, Cham, 2023: 133-177.
    1. Ghafoor A, Sundar S, Karunaratne T, Rao SS, Sharma A. Neurology and the gut: Autonomic neuropathy and dysautonomia. In: Rao SSC, Parkman HP, McCallum RW, editors. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2nd ed. Academic Press, 2023: 345-359.
    1. Quiroz-Aldave J, Durand-Vásquez M, Gamarra-Osorio E, Suarez-Rojas J, Jantine Roseboom P, Alcalá-Mendoza R, Coronado-Arroyo J, Zavaleta-Gutiérrez F, Concepción-Urteaga L, Concepción-Zavaleta M. Diabetic neuropathy: Past, present, and future. Caspian J Intern Med. 2023;14:153–169. - PMC - PubMed

MeSH terms